Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer

被引:0
|
作者
Panasci, LC [1 ]
机构
[1] Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada
关键词
D O I
10.1200/JCO.2006.05.7562
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2392 / 2392
页数:1
相关论文
共 50 条
  • [31] CHEMOTHERAPY FOR NODE-NEGATIVE BREAST-CANCER
    JONES, SE
    CANCER INVESTIGATION, 1986, 4 (05) : 501 - 501
  • [32] Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial
    Albain, K.
    Gray, R. J.
    Sparano, J. A.
    Makower, D. F.
    Pritchard, K. I.
    Hayes, D. F.
    Geyer, C. E., Jr.
    Dees, E. C.
    Goetz, M. P.
    Olson, J. A., Jr.
    Lively, T.
    Badve, S. S.
    Saphner, T. J.
    Wagner, L. I.
    Whelan, T. J.
    Ellis, M. J.
    Paik, S.
    Wood, W. C.
    Ravdin, P. M.
    Keane, M. M.
    Gomez, H. L.
    Reddy, P. S.
    Goggins, T. F.
    Mayer, I. A.
    Brufsky, A. M.
    Toppmeyer, D. L.
    Kaklamani, V. G.
    Berenberg, J. L.
    Abrams, J.
    Sledge, G. W., Jr.
    CANCER RESEARCH, 2019, 79 (04)
  • [33] Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score
    Meisel, Jane
    Zhang, Chao
    Neely, Cameron
    Menduza, Pia
    You, Shuo
    Han, Tatiana
    Liu, Yuan
    Sahin, Aysegul A.
    O'Regan, Ruth
    Li, Xiaoxian
    CLINICAL BREAST CANCER, 2018, 18 (05) : 347 - 352
  • [34] Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer
    Seitz, K.
    Goossens, C.
    Huebner, H.
    Gass, P.
    Uhrig, S.
    Heindl, F.
    Emons, J.
    Ruebner, M.
    Anetsberger, D.
    Hartmann, A.
    Beckmann, M. W.
    Erber, R.
    Hack, C. C.
    Fasching, P. A.
    Haeberle, L.
    ESMO OPEN, 2024, 9 (11)
  • [35] Association of endocrine therapy with overall survival in women with hormone receptor-positive, HER2-negative, node-negative breast cancer of favorable histology
    Oladeru, Oluwadamilola T.
    Singh, Anurag K.
    Ma, Sung Jun
    BREAST JOURNAL, 2020, 26 (10): : 2006 - 2010
  • [36] The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy
    Waks, Adrienne G.
    Stover, Daniel G.
    Guerriero, Jennifer L.
    Dillon, Deborah
    Barry, William T.
    Gjini, Evisa
    Hartl, Christina
    Lo, Wesley
    Savoie, Jennifer
    Brock, Jane
    Wesolowski, Robert
    Li, Zaibo
    Damicis, Adrienne
    Philips, Anne V.
    Wu, Yun
    Yang, Fei
    Sullivan, Amy
    Danaher, Patrick
    Brauer, Heather Ann
    Osmani, Wafa
    Lipschitz, Mikel
    Hoadley, Katherine A.
    Goldberg, Michael
    Perou, Charles M.
    Rodig, Scott
    Winer, Eric P.
    Krop, Ian E.
    Mittendorf, Elizabeth A.
    Tolaney, Sara M.
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4644 - 4655
  • [37] Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
    Hoon, Siao-Nge
    Lau, Peter K. H.
    White, Alison M.
    Bulsara, Max K.
    Banks, Patricia D.
    Redfern, Andrew D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (05):
  • [38] A robust prognostic signature for hormone-positive node-negative breast cancer
    Obi L Griffith
    François Pepin
    Oana M Enache
    Laura M Heiser
    Eric A Collisson
    Paul T Spellman
    Joe W Gray
    Genome Medicine, 5
  • [39] A robust prognostic signature for hormone-positive node-negative breast cancer
    Griffith, Obi L.
    Pepin, Francois
    Enache, Oana M.
    Heiser, Laura M.
    Collisson, Eric A.
    Spellman, Paul T.
    Gray, Joe W.
    GENOME MEDICINE, 2013, 5
  • [40] Role of adjuvant chemotherapy in small (≤5 mm) node-negative and hormone receptor-negative breast cancer.
    Master, Samip R.
    Dadi, Neelakanta
    Shah, Chintan
    Von Burton, Gary
    Shi, Runhua
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)